SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Henckaerts, E. Articles by Snoeck, H.-W. Search for Related Content PubMed PubMed Citation Articles by Henckaerts, E. Articles by Snoeck, H.-W. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 June 2002, Vol. 99, No. 11, pp. 3947-3954 HEMATOPOIESIS Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines Els Henckaerts, Hartmut Geiger, Jessica C. Langer, Patricia Rebollo, Gary Van Zant, and Hans-Willem Snoeck From the Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, New York, NY; and the Markey Cancer Center, University of Kentucky, Lexington.     Abstract Top Abstract Introduction Materials and methods Results Discussion References Quantitative trait analysis may shed light on mechanisms regulating hematopoiesis in vivo. Strain-dependent variation existed among C57BL/6 (B6), DBA/2, and BXD recombinant inbred mice in the responsiveness of primitive progenitor cells to the early-acting cytokines kit ligand, flt3 ligand, and thrombopoietin. A significant quantitative trait locus was found on chromosome 2 that could not be confirmed in congenic mice, however, probably because of epistasis. Because it has been shown that alleles of unknown X-linked genes confer a selective advantage to hematopoietic stem cells in vivo in humans and in cats, we also analyzed reciprocal male D2B6F1 and B6D2F1 mice, revealing an X-linked locus regulating the responsiveness of progenitor and stem cells to early-acting factors. Among DBA/2, B6, and BXD recombinant inbred mice, correlating genetic variation was found in the absolute number and frequency of LinSca1++kit+ cells, which are highly enriched in hematopoietic progenitor and stem cells, and in the number of LinSca1++kit cells, a population whose biologic significance is unknown, suggesting that both populations are functionally related. Suggestive quantitative trait loci (QTLs) for the number of LinSca1++ cells on chromosomes 2, 4, and 7 were confirmed in successive rounds of mapping. The locus on chromosome 2 was confirmed in congenic mice. We thus demonstrated genetic variation in the response to cytokines critical for hematopoiesis in vivo and in the pool size of cells belonging to a phenotype used to isolate essentially pure primitive progenitor and stem cells, and we identified loci that may be relevant to the regulation of hematopoiesis in steady state. (Blood. 2002;99:3947-3954) © 2002 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Hematopoiesis consists of an ordered series of events in which primitive hematopoietic stem cells renew or differentiate into mature blood cells of at least 8 lineages. The exact mechanisms responsible for the regulation of self-renewal versus differentiation of hematopoietic stem cells in vivo are unknown but may involve stochastic mechanisms and a balance between stimulatory and inhibitory signals regulating renewal, differentiation, and apoptosis.1 One strategy to gain insight into the regulation of hematopoiesis is to study naturally occurring genetic variation in the hematopoietic system. This may lead to the identification of regulatory mechanisms that are relevant in vivo. Pool size and cycling activity of the stem cell compartment are under complex intrinsic genetic control in inbred mouse strains.2-8 Putative stem cell pool size, as determined by the day 35 cobblestone area-forming cell assay (CAFCd35), varies widely among inbred mouse strains.2 This was not the case for earlier appearing, and therefore more mature, CAFCd7, indicating that the gene(s) involved act on the more primitive progenitor compartment.8 Using BXD recombinant inbred (RI) mouse strains, a locus involved in the regulation of CAFCd35 frequency was mapped to mouse chromosome 18, in a region syntenic with and corresponding to a critical segment of human chromosome 5q, which is frequently deleted in myelodysplasia and acute myeloblastic leukemia.2 Muller-Sieburg and Riblet, using a different assay in BXD mice, mapped 2 candidate loci regulating the number of long-term culture-initiating cells (LTC-IC) to mouse chromosome 1.3 Further evidence for the existence of intrinsic genetic control of hematopoietic stem cell kinetics comes from embryo-aggregated chimeric DBA/2B6 mice. In these mice, DBA/2-derived stem cells contribute significantly and stably to hematopoiesis in young adults, but with aging, B6-derived hematopoiesis becomes predominant, if not exclusive.5 Hematopoietic recovery after the administration of the myelotoxic drug 5-fluorouracil to young B6DBA/2 chimeras was significantly faster in the DBA/2-derived stem cell compartment than in the B6-derived compartment.6 Similarly, when chimeric bone marrow was transplanted, early engraftment of irradiated hosts was predominantly DBA/2 derived, significantly out of proportion to the DBA/2 representation in the marrow graft, further suggesting a proliferative advantage for DBA/2-derived stem cells. Because the microenvironment in these chimeric mice was identical for both DBA/2- and B6-derived stem cells, stem cell-intrinsic mechanisms must be at the basis of these differences.6 Genetic variation has also been demonstrated in the repopulation capacity of hematopoietic stem cells. One of the CXB RI strains had a significantly higher capacity for long-term competitive repopulation in CByB6F1 recipient mice than any of the other CXB strains.7 Loci affecting the efficiency of mobilization of progenitor cells to the peripheral blood have been identified on chromosomes 2 and 11.9 In humans and in cats, evidence for genetically determined regulation of hematopoiesis comes from studies addressing X inactivation in the hematopoietic system in vivo.10-13 In as many as 50% of aging women, progressive skewing of X inactivation occurs in the hematopoietic system.10,11 Similar data were obtained in cats.12 Furthermore, skewed X chromosome inactivation in all hematopoietic lineages also occurs after bone marrow transplantation12 and after repeated chemotherapy with busulfan in cats.13,14 Human female monozygotic twins that show skewed X inactivation in the hematopoietic system with aging tend to inactivate the X chromosome from the same parent.11,15 Thus, alleles on the X chromosome confer a growth, survival, or reconstitution advantage to stem cells. Progressive skewing of X inactivation in the hematopoietic system is therefore likely to be caused to a large extent by hemizygous selection,12 ie, a selective advantage of one X chromosome over another, whereas stochastic mechanisms are less dominant.15 The aim of this study was to test the hypothesis that strain-dependent variation would exist in the response of primitive hematopoietic progenitor and stem cells, as defined by the LinSca1++kit+ phenotype,16-18 to the early-acting factors kit ligand (KL), flt3 ligand (flt3L), and thrombopoietin (TPO). These factors have been shown to be critical to the function of the hematopoietic stem cell compartment in vivo.19-21 We show here that there is indeed strain-dependent variation in the response to these early-acting factors and that at least one locus for this trait maps to the X chromosome. In addition, we found strain-dependent variation in the absolute number and frequency of LinSca1++ cells (c-kit+ and c-kit subpopulations). A quantitative trait locus (QTL) for this trait on chromosome 2 was confirmed in congenic mice.     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Mice Female mice of strains C57BL/6J (B6), DBA/2J, and BXD RI, aged 6 to 8 weeks, were all purchased from Jackson Laboratories (Bar Harbor, ME). The mice were maintained in a germ-free environment and fed ad libitum. Experiments and animal care were performed in accordance with the Mount Sinai Institutional Animal Care and Use Committee. Antibodies and cytokines Unconjugated Ter119 (erythroid), CD2 (T and NK cells), CD3, CD4, CD8 (T cells), B220 (B cells), Ly6G/Gr1 (granulocytes), Mac1 (macrophages), phycoerythrin-conjugated Sca1, biotin-conjugated anti-c-kit, Cychrome-conjugated streptavidin, and fluorescein isothiocyanate-conjugated goat antirat antibodies were purchased from PharMingen (San Diego, CA). Recombinant mouse flt3L and thrombopoietin (TPO) and anti-transforming growth factor- (anti-TGF-) antibodies were purchased from R&D Systems (Minneapolis, MN). Supernatants from BHK/HM-5, BHK/MKL (both a kind gift of Dr J. Matous, University of Washington), and WEHI 3B (a kind gift of Dr S Tsai, Mount Sinai School of Medicine, New York, NY) cells were used as a source of granulocyte macrophage-colony-stimulating factor (GM-CSF), KL, and interleukin-3 (IL-3), respectively. Isolation of LinSca1+/+ cells Femurs and tibias were flushed with Iscoves modified Dulbecco medium (IMDM; Gibco BRL, Grand Island, NY) supplemented with 10% fetal calf serum (FCS). Low-density bone marrow cells, obtained after density centrifugation, were stained with Ter119, CD2, CD3, CD8, CD4, B220, Mac1, and Gr1 for 20 minutes at 4°C, washed, and stained with goat antirat antibodies for 20 minutes at 4°C. After washing, the cells were stained for 20 minutes at 4°C with phycoerythrin-conjugated Sca1 and biotin-conjugated CD117 (c-kit), washed with phosphate-buffered saline, and stained with streptavidin-Cychrome. Cells were sorted on a MoFlo flow cytometer (Cytomation, Fort Collins, CO) at 30 psi sheath pressure and at a rate of 12 000 to 15 000 events per second. Cells with a low side scatter, a low-to-medium forward scatter (Figure 1, R1), a green (lineage) fluorescence lower than the median fluorescence of cells stained with isotype-matched control antibodies, and an orange (Sca1) fluorescence twice the intensity (in terms of channel numbers) of the brightest cells in control samples (Figure 1, R2) were sorted as LinSca1++ cells. Cells falling in R1 and R2 with positive red (c-kit) fluorescence (Figure 1, R3) were sorted as LinSca1++kit+ cells, whereas cells falling in R1 and R2 with negative red fluorescence (Figure 1, R4) were sorted as LinSca1++kit cells. The absolute number of cells in each population was estimated by recording the number of sorted cells, as indicated by the number of sortable events on the counter of the cell sorter. The abort frequency was less than 5% in the sorting conditions we used. Bone marrow pooled from at least 2 mice was used in each experiment. Because the secondary goat antirat antibodies were not blocked with rat immune globulins, most Lin+ cells appear Sca1+ in Figure 1. This blocking step was omitted because only lineage-negative cells were isolated, and the blocking step did not affect the fluorescence or the number of the cells in the sort windows in preliminary experiments. View larger version (24K): [in this window] [in a new window]   Figure 1. Sort windows used to isolate LinSca1++, LinSca1++kit+, and LinSca1++kit cells. Cells with low to medium forward scatter (FSC) and low side scatter (SSC) (R1), negative green (lineage) fluorescence, orange (Sca1) fluorescence higher than twice the fluorescence level of cells stained with control antibodies (not shown) (R2), and positive red (c-kit) fluorescence (LSK+, R3) or negative red fluorescence (LSK, R4) were isolated. For the isolation of LinSca1++ cells, cells falling into R1 and R2 were isolated. Pre-colony-forming cell assay Lin-Sca1++ or LinSca1++kit+ cells were cultured in triplicate at approximately 50 cells per well in flat-bottom, 96-well plates in serum-free media (StemPro34; Gibco BRL), 50 ng/mL flt3L, 50 ng/mL TPO, and 10% BHK/KL supernatant (containing kit ligand). Because the BHK/KL supernatant contained 10% FCS, the actual serum concentration in these cultures was still 1%. Three hours after plating, the exact number of cells per well was determined by visually counting the cells at × 40 magnification. After 5 days of liquid culture at 37°C and 5% CO2, the cells were counted, and 500 cells were plated in methylcellulose cultures containing IMDM, IL-3 (10% of WEHI 3B supernatant), GM-CSF (10% of BHK/HM-5 supernatant), KL (10% of BHK/MKL supernatant), erythropoietin (2 U/mL), FCS (20%), anti-TGF- (10 µg/mL), and 2-mercaptoethanol (106 M). After 8 days of incubation at 37°C in a humidified incubator with 5% CO2, the cultures were scored for colony formation. The same lot of fetal bovine serum was used in all the experiments. Statistical analysis Student t test for unpaired samples was used, unless indicated otherwise. Congenic mice Congenic mice were generated by marker-assisted back-crossing22,23 using B6 and BXD-31Ty as founders. These B6.DBA/2-(D2Mit133-D2Mit200) congenic animals have a segment of chromosome 2 between 66.7 and 102 cm, derived from DBA/2 on a B6 background, and were obtained after 5 generations of male back-crossing and genotype-based selection with genetic markers spaced approximately 20 cM apart. Analysis of polymorphic simple sequence repeat elements was made by polymerase chain reaction using primers obtained from Research Genetics (Huntsville, AL). Quantitative trait analysis using BXD RI strains Recombinant inbred strains were generated by repeated inbreeding of F2 mice derived from 2 parental inbred strains, C57BL/6 (B6) and DBA/2 in the case of BXD RI strains. The genome of RI strains is composed of a patchwork of homozygous chromosome segments derived from either progenitor strain, with each of the RI lines having a unique combination of patches from the progenitor. Genetic maps are available for each RI strain that allow the mapping of traits specified by loci at which the parental strains are polymorphic.24,25 Linkage analysis is performed by determining the relevant trait in each of the strains of a set of RI strains, which results in a strain distribution pattern (SDP). The data are then analyzed using Map Manager QTb29ppc software developed by Manly.26 This software statistically analyzes the linkage of a given trait with previously typed polymorphic loci in the RI strains, which are inherited from either parental strain. This allows the assignment of a trait to a corresponding map position and the calculation of statistical significance.27 Statistical analysis. Because of the limited number of RI strains available, the number of SDPs to be compared, and, consequently, the complexity of testing required to establish concordance, a close or identical match in SDPs may occur by chance.27,28 As with all statistical comparisons, it is necessary to make a calculation of the probability that the observed result was a false-positive. Therefore, the genome-wide probability of obtaining the observed linkages by random chance, corresponding to an error threshold of P = .05, is calculated using the robust nonparametric permutation method developed by Churchill and Doerge,27 which is implemented in the Map Manager QTb29ppc software developed by Manly et al.26 The peak logarithm of the likelihood of odds ratio (the LOD score) of the correctly ordered data obtained in our study is compared with the peak LOD scores computed for 5000 random permutations of the same data. As an example of this kind of analysis, if the actual data gave an LOD score of 6 and only 1 in 1000 random permutations exceeded this value, the genome-wide probability of a false-positive would be approximately 0.001. The P = .5 error threshold, a level considered suggestive of a QTL, corresponds to a LOD score that is exceeded by the highest LOD scores of half the permutations.27 Interval mapping. A subroutine of the Map Manager QTb29ppc software, using computationally efficient regression equations, is used for mapping the QTLs. The probability of linkage between our trait under study and previously mapped genotypes was estimated at 1-cM intervals along the entire genome, except for the Y chromosome. The statistical power of linkage of the phenotype to individual genotypes (point-wise linkage statistics) should attain values of at least 0.0001 to reach a level of genome-wide statistical significance.27,28 Mapping databases. Mapping databases were downloaded from www.nervenet.org/papers/bxn.html.29     Results Top Abstract Introduction Materials and methods Results Discussion References Responsiveness to early-acting factors and number of phenotypically defined progenitor cells in B6 and DBA/2 mice A pre-colony-forming cell (pre-CFC) assay was used to measure proliferation and differentiation capacity of LinSca1++kit+ cells,16-18 isolated by flow cytometric cell sorting according to the sort windows shown in Figure 1, from B6 and DBA/2 mice. In this assay, LinSca1++kit+ cells were cultured in liquid cultures supported by the early-acting factors KL, flt3L, and TPO.19-21 After 5 days of culture, the cells were counted and plated in methylcellulose assays supported by KL, IL-3, GM-CSF, erythropoietin, and neutralizing anti-TGF- antibodies for the determination of CFC content. B6 and DBA/2 mice were chosen for these studies because of the known strain-dependent variation in the hematopoietic system between these 2 mouse strains2-6,8,9 and because of the availability of a relatively large set of BXD RI strains together with a dense map of polymorphic markers.24-26,29 LinSca1++kit+ cells from B6 mice proliferated better in response to flt3L, KL, and TPO than LinSca1++kit+ cells from DBA/2 mice (P = .01, n = 12, paired t test; Figure 2A). The difference in CFC generation was not statistically significant (n = 12, Figure 2A). Most colonies generated were myeloid, with 20% to 40% macroscopic colonies derived from high proliferative potential cells. During these experiments, we also recorded the number of sorted LinSca1++kit+ events, as determined on the counter on the cell sorter, as well as the frequency of LinSca1++kit+ cells. The frequency (not shown) and the absolute number (Figure 2B) of LinSca1++kit+ cells were 2-fold higher in B6 than in DBA/2 mice (P = .04, n = 8). Long-term repopulating stem cells are enriched in the LinSca1++kit+ fraction of bone marrow cells.16-18 In addition, a c-kit subpopulation of LinSca1++ cells has been identified by Randall and Weissman that does not proliferate in vitro and that has no detectable long-term repopulating capacity.30 In addition, in our hands, these cells did not respond to flt3L, KL, or TPO at all (n = 16, not shown). The biologic significance of this population is unknown. We noticed, however, that the number of LinSca1++kit cells was also 2-fold higher in B6 than in DBA/2 mice (P = .04, n = 8, Figure 2B). When, in a separate set of experiments, the total number of LinSca1++ cells was quantified, the number in B6 mice was again 2-fold higher than in DBA/2 mice (P = .02, n = 6, Figure 2B). These data suggest that the size of the LinSca1++ population as a whole is genetically determined. An alternative explanation might be that B6 and DBA/2 mice simply differ in the level of expression of Sca1, so that it would appear that DBA/2 mice have a lower number of Sca1++ cells. However, the range of expression levels of Sca1 on Lin cells in B6 and DBA/2 mice (Figure 2C) was identical. It is therefore unlikely that the observed 2-fold variation in the numbers of LinSca1++ cells was caused by variation in the relative level of expression of the Sca1 antigen. View larger version (23K): [in this window] [in a new window]   Figure 2. Proliferative capacity and number of LinSca1++kit+ and LinSca1++kit cells in B6 and DBA/2 mice. (A) Number of cells and CFCs obtained after 5 days of liquid culture of 50 LinSca1++kit+ cells from B6 and DBA/2 mice supported by KL, flt3L, and TPO. Results are given as mean ± SEM (n = 12 independent triplicate experiments; *significantly different from B6, paired t test). (B) Absolute number of LinSca1++, LinSca1++kit+, and LinSca1++kit cells in B6 and DBA/2 mice as determined by flow cytometric cell sorting (mean ± SEM, n = 8 independent experiments in which the bone marrow pooled from at least 2 mice was used; *significantly different from B6, paired t test). (C) Range of expression levels of Sca1 on Lin bone marrow cells from B6 and DBA/2 mice. Quantitative trait analysis in BXD RI strains To further investigate potential genetically determined variation in the cytokine responsiveness and number of LinSca1++ cells, we performed quantitative trait analysis using BXD RI strains. Twenty-eight BXD RI strains were analyzed for responsiveness to the early-acting factors flt3L, KL, and TPO, for the absolute number and frequency of LinSca1++ cells, and for the fraction of c-kit+ cells among LinSca1++ cells. In all RI strains, at least 3 independent experiments were performed in triplicate using bone marrow pooled from at least 2 individual mice in each experiment. The strain distribution patterns are shown in Figure 3. Because LinSca1++kit cells do not respond to early-acting cytokines at all (n = 16), only LinSca1++kit+ cells are responsible for cell proliferation and CFC generation from LinSca1++ cells. Table 1 summarizes the map positions obtained. View larger version (34K): [in this window] [in a new window]   Figure 3. Strain-distribution patterns in BXD mice. Strain-distribution pattern of (A) the proliferation of LinSca1++ cells in response to KL, flt3L, and TPO (expressed as cell number after 5 days of culture per 50 input LinSca1++ cells), (B) the absolute number of LinSca1++ cells, (C) the relative fraction of LinSca1++ cells, and (D) the fraction of c-kit+ cells among LinSca1++ cells in 8- to 10-week-old BXD RI mice (mean ± SEM, n = 3 independent experiments in which the bone marrow pooled from at least 2 mice was used).                                View this table: [in this window] [in a new window]   Table 1. Overview of mapped QTLs There was wide phenotypic variation among BXD RI strains for proliferative capacity in response to flt3L, KL, and TPO. Cell number per 50 input LinSca1++ cells after 5 days of culture ranged from 124 ± 72 (BXD6) to 4369 ± 2119 (BXD5) (Figure 3A). CFC output completely paralleled cellular proliferation, and no strain-dependent variation was noted in the secondary cloning efficiency (not shown). It was surprising that up to 35-fold variation in the proliferative capacity was seen among BXD RI strains (Figure 3A), whereas there was only a small difference in this trait among the 2 progenitor strains (Figure 2A), indicating that this is a multigenic, quantitative trait. For multigenic traits, phenotypic spread among BXD strains actually represents the phenotypic spread in the F2 generation, not of the progenitor strains. Therefore, extensive phenotypic variation can be seen within the RI strains, even when the phenotype of the 2 progenitor strains is not significantly different for that trait. The reason is that RI strains may have most of the positive or most of the negative alleles contributing to a given trait, whereas the 2 progenitor strains may have both positive and negative alleles for that trait.24,25 A major QTL for proliferative capacity was found on chromosome 2, with a likelihood ratio statistic (LRS) in the significant range as determined by permutation analysis. Interval mapping showed the highest LRS value (18.8) between D2Mit495 (73.2 cM) and D2Mit411 (77.6 cM) (Table 1). The donor of the high allele was B6. Among the 28 BXD RI strains studied, the number of LinSca1++ cells varied from 721 ± 86 (BXD6) to 6472 ± 447 (BXD28) cells per femur (Figure 3B). The percentage of LinSca1++ cells in the bone marrow (Figure 3C) correlated well with the absolute number of LinSca1++ cells (r = 0.870, P < .0001, not shown). This correlation indicates that the fraction of LinSca1++ cells is a good measure of the absolute number of LinSca1++ cells and that our data cannot be explained by genetically determined variation in bone marrow cellularity. In addition, the range of expression of Sca1 was the same in all BXD strains, indicating again that differences in the expression levels of Sca1 cannot explain the variation in the number of LinSca1++ cells. Although there was some variation in the ratio of c-kit+/c-kit cells among LinSca1++ cells in BXD RI strains, no statistically significant differences were found (Figure 3D; only strains in which 3 experiments were performed are shown). Variation in the fraction of c-kit-expressing LinSca1++ cells thus cannot explain the 35-fold variation in proliferative capacity of LinSca1++ cells. The 9-fold variation in the number of LinSca1++ cells among BXD RI strains compared with the only 2-fold difference between the 2 progenitor strains, B6 and DBA/2, suggest that the number of LinSca1++ cells is a complex multigenic trait. Quantitative trait analysis was performed for the number of LinSca1++ cells using the average values for the 3 independent experiments performed in each BXD strain (Table 1). This analysis revealed a highly suggestive QTL for the number of LinSca1++ cells on chromosome 4 (Table 1). The highest value of the LRS (15.9) by interval mapping was found between D4Mit33 (77.5cM) and D4Mit343 (79 cM). This was just short of significant, for which an LRS of 16.6 was required according to permutation analysis.27 The frequency of LinSca1++ cells mapped to the same region of chromosome 4 with a suggestive level of significance (LRS 12.7). The donor of the high allele was DBA/2. A second suggestive QTL (LRS 9.4 for absolute number and 11.4 for frequency of LinSca1++ cells) was found on chromosome 2, between D2Mit495 (73.2 cM) and D2Mit411 (77.6 cM). The donor of the high allele at this locus was B6. A third, weaker QTL was found on chromosome 7 between D7Mit17 (51 cM) and D7Mit238 (53 cM); B6 was the donor of the high allele (LRS 9.2). The level of significance of the association with all 3 loci was in the suggestive range according to published criteria. This means that the association is likely but needs confirmation.25,27,28 However, the same 3 loci were also found, again with a level of statistical significance in the suggestive range, when each round of mapping was analyzed individually. Therefore, each of these QTLs has been confirmed in successive, independent rounds of linkage analysis.25 Interestingly, the QTL on chromosome 2 for the number of LinSca1++ cells overlaps with the QTL on chromosome 2 for the proliferative capacity of LinSca1++ cells. In addition, there was a significant correlation between proliferation and the number and frequency of LinSca1++ cells among BXD RI strains (Figure 4A; data shown for absolute number of LinSca1++ cells), and the pattern of LRS values along chromosome 2 was virtually identical for both traits (Figure 4B). Taken together, these data may suggest that genetic variation in the responsiveness to early-acting cytokines contributes to the regulation of the absolute number of LinSca1++ cells among BXD RI strains. View larger version (27K): [in this window] [in a new window]   Figure 4. Responsiveness to early-acting factors and number of LinSca1++ cells in BXD RI strains. (A) Correlation between the responsiveness to flt3, KL, and TPO and number of LinSca1++ cells per femur among BXD RI strains. (B) LRS along chromosome 2 (chr 2) for the number of LinSca1++ cells per femur (top) and proliferation (bottom). Confirmation of a locus on chromosome 2 determining the number of LinSca1++kit+ cells in congenic mice Congenic mice22,23,25 were constructed in the laboratory of GvZ, where a segment from chromosome 2 between D2Mit133 (66.7 cM) and D2Mit200 (102 cM), encompassing the region containing a QTL for the number of LinSca1++ cells and for their proliferative capacity (Table 1), from DBA/2 mice was crossed onto the B6 background (B6.DBA/2-[D2Mit133-D2Mit200] mice). We determined whether introgression of this DBA/2-derived segment of chromosome 2 onto the B6 background would change the number of LinSca1++, LinSca1++kit+, and LinSca1++kit cells and their responses to flt3L, KL, and TPO toward the values obtained for DBA/2 (Figure 2). Mice congenic for the distal region of chromosome 4 or chromosome 7 are not yet available. As shown in Figure 5, congenic mice had significantly fewer LinSca1++kit+ cells (P = .0075) than B6 mice, whereas the difference in the number of LinSca1++kit cells (P = .1) and total LinSca1++ cells (P = .07) was at the limit of statistical significance by paired t test. Our data thus confirm that the segment of chromosome 2 between 66.8 and 107 cM contains at least one gene that contributes to the regulation of the pool size of LinSca1++kit+ cells and possibly also of LinSca1++kit cells, that this gene shows allelic variation between B6 and DBA/2 mice, and that DBA/2 was the donor of the low allele for this trait. View larger version (26K): [in this window] [in a new window]   Figure 5. Number of LinSca1++, LinSca1++kit+, and LinSca1++kit cells in congenic mice. (A) Average number (mean ± SEM, n = 8) of LinSca1++, LinSca1++kit+, and LinSca1++kit cells per femur in B6 and B6.DBA/2-(D2Mit133-D2Mit200) congenic mice (the latter are indicated in the figure as B6.D2-chr2). Cell numbers were determined by cell sorting. P values (paired t test) are given at the tops of the figures. We anticipated seeing lower proliferative capacity and CFC generation in LinSca1++kit+ cells from congenic mice than from B6 mice. However, proliferation and CFC generation were identical in B6 and congenic mice (not shown, n = 8). The QTL on chromosome 2 for proliferative capacity could thus not be confirmed in congenic mice. Evidence for X-linked genetic factors in the regulation of the response of primitive hematopoietic stem and progenitor cells to early-acting cytokines in mice Alleles of unknown X-linked genes confer a selective advantage to hematopoietic stem cells in vivo in humans and in cats.10-15 No models or in vitro assays are available to investigate X-linked regulation of hematopoiesis in the mouse. Furthermore, quantitative trait analysis with the available number of BXD RI strains does not detect all QTLs involved in complex traits.24,25 We therefore tried to establish a model to detect X-linked allelic variation in the hematopoietic stem cell compartment by investigating whether reciprocal male B6D2F1 and D2B6F1 mice differed in the number of LinSca1++kit+ and LinSca1++kit cells and in the responsiveness of LinSca1++kit+ to early-acting cytokines. Female D2B6F1 and B6D2F1 mice are heterozygous in all their loci, and X inactivation is random.31 Therefore, the phenotype of reciprocal female F1 hybrids will be the same, unless there is allelic variation in imprinted genes, so that a parent-of-origin effect is observed. Reciprocal male F1 hybrids, however, differ in the origin of the unique X chromosome (B6 in B6D2F1 mice, and DBA/2 in D2B6F1 mice). Phenotypic variation between reciprocal male F1 hybrids is thus most likely caused by allelic variation at X-linked loci. Theoretically, it is also possible that allelic variation at Y-linked loci exists. The numbers of LinSca1++kit+ and LinSca1++kit cells in female and male F1 hybrids were intermediate between those for the parental strains, indicating that it is unlikely that X-linked genes regulate the number of LinSca1++kit+ or LinSca1++kit cells in vivo (not shown, n = 8). Proliferation (Figure 6A) and CFC production (Figure 6B) were similar in female B6D2F1 and D2B6F1 mice (n = 4). This is in accordance with complete heterozygosity in autosomal loci and random X inactivation in female F1 hybrids.31 In contrast to female F1 hybrid mice, however, proliferation (Figure 6A) and CFC generation (Figure 6B) in LinSca1++kit+ cells from male D2B6F1 mice were significantly higher than in LinSca1++kit+ cells from male B6D2F1 mice (n = 8). Because male D2B6F1 and B6D2F1 mice are heterozygous in all their autosomal loci but differ in the origin of the X chromosome (B6 in B6D2F1 mice and DBA/2 in D2B6F1 mice), these data suggest that at least one X-linked locus contributes to the regulation of the response of LinSca1++kit+ cells to early-acting factors and that the donor of the high allele is DBA/2. As mentioned before, genetic variation in Y-linked genes could theoretically also explain our data. Although this cannot be formally excluded, the involvement of Y-linked genes is less likely given the paucity of somatically active genes on the Y chromosome.32 In addition, if allelic variation between DBA/2 and B6 mice on the Y chromosome plays a role, then one would expect a differential effect of sex on this trait in B6 and DBA/2 mice, which was not the case (not shown). View larger version (17K): [in this window] [in a new window]   Figure 6. Difference in proliferative capacity in reciprocal male and female F1 hybrid mice. Cell proliferation (A) and CFC generation (B) per 50 input LinSca1++kit+ cells isolated from male and female D2B6F1 and B6D2F1 hybrid mice. Results are given as mean ± SEM. P values indicated on the figure were obtained by paired t test (n = 4 for female D2B6F1 and B6D2F1 mice; n = 8 for male D2B6F1 and B6D2F1 mice).     Discussion Top Abstract Introduction Materials and methods Results Discussion References In this study, we have identified 2 significant traits involving the hematopoietic stem and progenitor cell compartment that show quantitative variation: (1) responsiveness to early-acting hematopoietic cytokines and (2) absolute number of LinSca1++ cells (both c-kit+ and c-kit subpopulations). Variation in the fraction of LinSca1+ cells among inbred mouse strains was already noted previously by Spangrude and Brooks.33 LinSca1++ cells are highly enriched in stem and progenitor cells16-18 but are still heterogeneous. Long-term repopulating cells are thought to be LinSca1++kithigh,1,16-18 though some reports suggest that a kit precursor of kithigh repopulating stem cells exists.34 LinSca1+kitlow cells have been shown to be enriched in early-lymphoid precursors,35 though lymphoid-committed precursors have recently been identified in the Linkithigh population as well.36 A LinSca1+kit population has been described by Randall and Weissman30 in steady state bone marrow. This mystery population is quiescent, increases in size with aging, does not proliferate in vitro, and does not contain long-term repopulating activity. We did indeed reproduce these findings (J.C.L. and H.-W.S., unpublished observations, December 2001). The functional significance of this LinSca1++kit population is unknown. We show here that at least 3 loci determine the total number of LinSca1++ cells: one on chromosome 2, one on chromosome 7, and one on chromosome 4. Because we found that there was little variation in the ratio of kit+/kit cells among LinSca1++ cells, despite a 10-fold variation in the total number of LinSca1++ cells in BXD strains (Figure 3), we conclude that the number of LinSca1++kit+ and LinSca1++kit cells are regulated by at least partially overlapping genetic mechanisms. Indeed, the number of LinSca1++kit+ and LinSca1++kit cells is 2-fold higher in B6 than in DBA/2 mice. These mechanisms are not necessarily identical, nor do they necessarily affect each subpopulation to the same extent. In congenic mice, we find a significant effect of the DBA-derived segment of chromosome 2 on the number of LinSca1++kit+ cells, but the effect on the number of LinSca1++kit and total LinSca1++ cells numbers is at the limit of statistical significance, possibly suggesting that this locus mainly regulates the number of LinSca1++kit+ cells. This will, of course, be reflected in the size of the total LinSca1++ population, for which we have demonstrated linkage on chromosome 2 in BXD RI strains. Although the biologic significance of a small change in the number of LinSca1++ cells caused by a single locus may be limited, the combined effect of many loci affecting pool size of LinSca1++ cells, as in those BXD mice with extreme values, is likely to be important. In addition, the importance of our data lies in the fact that we show that multiple loci affecting the number of LinSca1++ cells exist. This may lead to identification of the mechanisms that regulate the number of LinSca1++ cells and of the kit+ and kit subpopulations thereof. The correlation between the response to flt3L, KL, and TPO and the number of LinSca1++ cells among BXD RI strains and the overlapping QTLs for both traits raise the possibility that the responsiveness to early-acting cytokines plays a role in determining the number of LinSca1++ cells. However, a phenotype could be reproduced in mice congenic for the locus on chromosome 2 for the number of LinSca1++kit+ and LinSca1++kit cells, but not for proliferative capacity in response to KL, flt3L, and TPO. The most likely explanation for the lack of a proliferative phenotype in the congenic mice is epistasis with other loci that show allelic variation.25,37 In addition, a locus was found on the X chromosome that clearly determines the response of LinSca1++kit+ cells to early-acting factors, but it has no effect on the number of LinSca1++kit+ or LinSca1++kit cells. Our data thus suggest that genetic variation in the response to early-acting cytokines does not determine the number of LinSca1++kit+ or Lin-Sca1++kit cells. This is in accordance with the data of Miller et al,38 who showed that the number of stem cells, as defined by the LinSca1+WGA+ phenotype, is similar in W mutant and wild-type mice. The correlation between the response to early-acting factors and the number of LinSca1++ cells is most likely explained by the fact that linked, but distinct, QTLs on chromosome 2 are major determinants for both traits. Other QTLs related to hematopoiesis have been mapped to this segment of chromosome 2. In several studies,8,39 a suggestive QTL on chromosome 2 at approximately 50 cM, regulating the increase of the number of CAFCd35 with aging in B6 and DBA/2 mice has been reported. Hasegawa et al9 identified a significant QTL that controls the efficiency of mobilization of hematopoietic progenitor cells in response to GM-CSF on chromosome 2 between 46 and 86 cM.9 It was recently shown that the mobilization of hematopoietic stem cells occurs after the M-phase of the cell cycle.40 Therefore, it is possible that an allele responsible for a higher responsiveness to early-acting factors also causes more efficient mobilization of hematopoietic stem cells. Potential candidate genes in this region of chromosome 2 known to play a role in hematopoiesis include jag1 (encoding the Notch ligand Jagged-1),41 bmp2 (encoding BMP-2),42 and the il1 complex (encoding IL-1 and IL-1, respectively).43 QTL analysis, as reported here and by others,2-6,8,9 demonstrates differential genetic regulation of the size of the stem and progenitor cell compartment, as defined by immunophenotype on one hand and by functional assays on the other hand. Our data show that LinSca1++kit+ cells are more numerous in B6 than in DBA/2 mice, confirming an earlier report in which the WGA++Linrho123low phenotype was used to isolate and identify the most primitive hematopoietic precursors.6 Yet, LinSca1++kit+ cells from DBA/2 mice repopulate syngeneic recipients more efficiently than those of B6 mice and generate more CAFCd35.44 In addition, DBA/2 mice show faster recovery after the administration of 5-fluorouracil than B6 mice44 and contain more CAFCd35 and LTC-IC than B6 mice.2,3,8 Conversely, data in allophenic mice suggest that on aging, B6-derived stem cells are more efficient at sustaining hematopoiesis.4,5 In CXB mice, long-term repopulation potential does not correlate with LTC-IC and CAFC numbers either.7 QTL analysis and subsequent identification of genes responsible for quantitative variation in the stem cell compartment, as defined by function and by phenotype, may provide novel insight into the regulation of hematopoiesis by helping to resolve these discrepancies. A possible explanation may be that the number of LinSca1++kit+ cells is a reflection of stem and progenitor cell pool size in steady state conditions, whereas assays such as CAFC, LTC-IC, and long-term repopulation assay45 reflect, among other things, the capacity of the stem cell compartment to respond to hematopoietic stress. The answer to whether the putative X-linked locus we identified here is the same as the locus that causes skewed X inactivation on aging in cats and in humans will have to await gene identification of the loci involved. However, given the importance of early-acting cytokines such as KL, flt3L, and TPO in vivo,19-21 allelic variation in one or more X-linked genes affecting the responsiveness to these cytokines is an attractive candidate mechanism for the large genetic component in the skewed X inactivation in elderly females in humans11,15 and in cats.12 Our study suggests that an easy assaymeasurement of the responsiveness to early-acting cytokines in vitromay allow mapping and identification of X-linked loci involved in the regulation of hematopoiesis. In summary, we demonstrated genetic variation in the response to cytokines critical for hematopoiesis in vivo and in the pool size of cells belonging to a phenotype used to isolate essentially pure primitive progenitor and stem cells, and we identified loci that may be relevant to the regulation of hematopoiesis in steady state.     Footnotes Submitted October 18, 2001; accepted January 23, 2002. Supported in part by National Institutes of Health grant RO1 AG16327 (H.-W.S.) and RO1 AG16653 (G.V.Z.). E.H. was supported by a fellowship from the Belgian American Educational Foundation and by the Belgian Hematological Society. H.G. was supported by a fellowship from the Deutsche Akademie der Naturforscher Leopoldina. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Hans-Willem Snoeck, Carl C. Icahn Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, Box 1496, One Gustave L. Levy Pl, New York, NY 10029; e-mail: hans.snoeck{at}mssm.edu.     References Top Abstract Introduction Materials and methods Results Discussion References 1. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Ann Rev Cell Dev Biol. 1995;11:35-71[CrossRef][Medline] [Order article via Infotrieve]. 2. de Haan G, Van Zant G. Intrinsic and extrinsic control of hematopoietic stem cell numbers: mapping of a stem cell gene. J Exp Med. 1997;186:529-536[Abstract/Free Full Text]. 3. Muller-Sieberg CE, Riblet R. Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med. 1996;171:1141-1150[Abstract/Free Full Text]. 4. Van Zant G, Eldridge PW, Behringer RR, Dewey MJ. Genetic control of hematopoietic kinetics revealed by analysis of allophenic mice and stem cell suicide. Cell. 1983;35:639-645[CrossRef][Medline] [Order article via Infotrieve]. 5. Van Zant G, Holland BP, Eldridge PW, Chen JJ. Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J Exp Med. 1990;171:1547-1565[Abstract/Free Full Text]. 6. Phillips R, Reinhart A, Van Zant G. Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics. Proc Natl Acad Sci U S A. 1992;89:11607-11611[Abstract/Free Full Text]. 7. Chen J, Astle CM, Muller-Sieburg CE, Harrison DE. Primitive hematopoietic stem cell function in vivo is uniquely high in the CXB-12 mouse strain. Blood. 2000;96:4124-4131[Abstract/Free Full Text]. 8. Geiger H, True J, de Haan G, Van Zant G. Age- and stage-specific regulation patterns in hematopoietic stem cell hierarchy. Blood. 2001;98:2966-2972[Abstract/Free Full Text]. 9. Hasegawa M, Baldwin TM, Metcalf D, Foote SJ. Progenitor cell mobilization by granulocyte colony-stimulating factor controlled by loci on chromosomes 2 and 11. Blood. 2000;95:1872-1874[Abstract/Free Full Text]. 10. Champion KM, Gilbert JG, Asimakopoulos FA, Hinshelwood S, Green AR. Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol. 1997;97:920-926[CrossRef][Medline] [Order article via Infotrieve]. 11. Christensen K, Kristiansen M, Hagen-Larsen H, et al. X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood. 2000;95:2449-2451[Abstract/Free Full Text]. 12. Abkowitz JL, Taboada M, Shelton GH, Catlin SN, Guttorp P, Kiklevich JV. An X chromosome gene regulates hematopoietic stem cell kinetics. Proc Natl Acad Sci U S A. 1998;95:3862-3866[Abstract/Free Full Text]. 13. Abkowitz JL, Ott RM, Holly RD, Adamson JW. Clonal evolution following chemotherapy-induced stem cell depletion in cats heterozygous for glucose-6-phosphate dehydrogenase. Blood. 1988;71:1687-1692[Abstract/Free Full Text]. 14. Abkowitz JL, Linenberger ML, Persik M, Newton MA, Guttorp P. Behavior of feline hematopoietic stem cells years after busulfan exposure. Blood. 1993;82:2096-2103[Abstract/Free Full Text]. 15. Vickers MA, McLeod E, Spector TD, Wilson IJ. Assessment of mechanism of acquired skewed X inactivation by analysis of twins. Blood. 2001;97:1274-1281[Abstract/Free Full Text]. 16. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58-62[Abstract/Free Full Text]. 17. Trevisan M, Iscove NN. Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny. J Exp Med. 1995;181:93-103[Abstract/Free Full Text]. 18. Okada S, Nakauchi H, Nagayoshi K, et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood. 1991;78:1706-1712[Abstract/Free Full Text]. 19. Kimura S, Roberts AW, Metcalf D, Alexander WS. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc Natl Acad Sci U S A. 1998;95:1195-1200[Abstract/Free Full Text]. 20. Solar GP, Kerr WG, Zeigler FC, et al. Role of c-mpl in early hematopoiesis. Blood. 1998;92:4-10[Abstract/Free Full Text]. 21. Lyman SD, Jacobsen SE. c-Kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101-1134[Free Full Text]. 22. Markel P, Shu P, Ebeling C, et al. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet. 1997;17:280-284[CrossRef][Medline] [Order article via Infotrieve]. 23. Wakeland E, Morel L, Achey K, Yui M, Longmate J. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today. 1997;18:472-477[CrossRef][Medline] [Order article via Infotrieve]. 24. Silver LM. Mouse Genetics: Concepts and Applications. Oxford, England: Oxford University Press; 1995. 25. Moore KJ, Nagle DL. Complex trait analysis in the mouse: the strengths, the limitations and the promises yet to come. Annu Rev Genet. 2000;34:653-686[CrossRef][Medline] [Order article via Infotrieve]. 26. Manly KF, Olson JM. Overview of QTL mapping software and introduction to map manager QT. Mamm Genome. 1999;10:327-334[CrossRef][Medline] [Order article via Infotrieve]. 27. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics. 1994;138:963-971[Abstract]. 28. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 1995;11:241-247[CrossRef][Medline] [Order article via Infotrieve]. 29. Williams RW, Gu J, Qi S, Lu L. The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis. Release 1, January 15, 2001 at www.nervenet.org/papers/bxn.html or mickey.utmem.edu/papers/bxn.html. 30. Randall TD, Weissman IL. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population? Stem Cells. 1998;16:38-48[Medline] [Order article via Infotrieve]. 31. Avner P, Heard E. X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet. 2001;1:59-67. 32. Charlesworth B, Charlesworth D. The degeneration of Y chromosomes. Philos Trans R Soc Lond B Biol Sci. 2000;355:1563-1572[Abstract/Free Full Text]. 33. Spangrude GJ, Brooks DM. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly6A/E by bone marrow cells. Blood. 1993;82:3327-3332[Abstract/Free Full Text]. 34. Ortiz M, Wine JW, Lohrey N, Ruscetti FW, Spence ER, Keller JR. Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development. Immunity. 1999;10:173-182[CrossRef][Medline] [Order article via Infotrieve]. 35. Mojica MP, Perry SS, Searle AE, et al. Phenotypic distinction and functional characterization of pro-B cells in adult mouse bone marrow. J Immunol. 2001;166:3042-3051[Abstract/Free Full Text]. 36. Medina KL, Garrett KP, Thompson LF, Rossi MI, Payne KJ, Kincade PW. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol. 2001;2:718-724[CrossRef][Medline] [Order article via Infotrieve]. 37. Flint J, Mott R. Finding the molecular basis of quantitative traits: successes and pitfalls. Nat Rev Genet. 2001;2:437-444[CrossRef][Medline] [Order article via Infotrieve]. 38. Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells. Exp Hematol. 1996;24:185-194[Medline] [Order article via Infotrieve]. 39. de Haan G, Van Zant G. Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood. 1999;93:3294-3301[Abstract/Free Full Text]. 40. Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, Weissman IL. Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood. 2001;97:2278-2285[Abstract/Free Full Text]. 41. Varnum-Finney B, Purton LE, Yu M, et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood. 1998;91:4084-4091[Abstract/Free Full Text]. 42. Bhatia M, Bonnet D, Wu D, et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 1999;89:1139-1148. 43. Ruscetti FW, Dubois CM, Jacobsen SE, Keller JR. Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis. Baillieres Clin Haematol. 1992;5:702-703. 44. de Haan G, Szilvassy SJ, Meyerrose TE, Dontje B, Grime B, Van Zant G. Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers. Blood. 2000;96:1374-1379[Abstract/Free Full Text]. 45. Harrison DE. Evaluating functional abilities of primitive hematopoietic stem cell populations. Curr Top Microbiol Immunol. 1992;177:13-30[Medline] [Order article via Infotrieve]. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: S. Avagyan, L. Glouchkova, J. Choi, and H.-W. Snoeck A Quantitative Trait Locus on Chromosome 4 Affects Cycling of Hematopoietic Stem and Progenitor Cells through Regulation of TGF-{beta}2 Responsiveness J. Immunol., November 1, 2008; 181(9): 5904 - 5911. [Abstract] [Full Text] [PDF] S. Vasu, S. F. Leitman, J. F. Tisdale, M. M. Hsieh, R. W. Childs, A. J. Barrett, D. H. Fowler, M. R. Bishop, E. M. Kang, H. L. Malech, et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population Blood, September 1, 2008; 112(5): 2092 - 2100. [Abstract] [Full Text] [PDF] M Jawad, G Giotopoulos, C Cole, and M Plumb Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S56 - S62. [Abstract] [Full Text] [PDF] F. Johannes Mapping Temporally Varying Quantitative Trait Loci in Time-to-Failure Experiments Genetics, February 1, 2007; 175(2): 855 - 865. [Abstract] [Full Text] [PDF] T. S. Fenske, C. McMahon, D. Edwin, J. C. Jarvis, J. M. Cheverud, M. Minn, V. Mathews, M. A. Bogue, M. A. Province, H. L. McLeod, et al. Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. Cancer Res., May 15, 2006; 66(10): 5029 - 5038. [Abstract] [Full Text] [PDF] R. Kumar, J. C. Langer, and H.-W. Snoeck Transforming growth factor-beta2 is involved in quantitative genetic variation in thymic involution Blood, March 1, 2006; 107(5): 1974 - 1979. [Abstract] [Full Text] [PDF] F. Martelli, B. Ghinassi, B. Panetta, E. Alfani, V. Gatta, A. Pancrazzi, C. Bogani, A. M. Vannucchi, F. Paoletti, G. Migliaccio, et al. Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds Blood, December 15, 2005; 106(13): 4102 - 4113. [Abstract] [Full Text] [PDF] Y. Liang, G. Van Zant, and S. J. Szilvassy Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells Blood, August 15, 2005; 106(4): 1479 - 1487. [Abstract] [Full Text] [PDF] H. Geiger, G. Rennebeck, and G. Van Zant Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element PNAS, April 5, 2005; 102(14): 5102 - 5107. [Abstract] [Full Text] [PDF] A. L. Smith, F. M. Ellison, J. P. McCoy Jr., and J. Chen c-Kit Expression and Stem Cell Factor-Induced Hematopoietic Cell Proliferation Are Up-Regulated in Aged B6D2F1 Mice J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2005; 60(4): 448 - 456. [Abstract] [Full Text] [PDF] E. Henckaerts, J. C. Langer, J. Orenstein, and H.-W. Snoeck The Positive Regulatory Effect of TGF-{beta}2 on Primitive Murine Hemopoietic Stem and Progenitor Cells Is Dependent on Age, Genetic Background, and Serum Factors J. Immunol., August 15, 2004; 173(4): 2486 - 2493. [Abstract] [Full Text] [PDF] E. Henckaerts, J. C. Langer, and H.-W. Snoeck Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice Blood, July 15, 2004; 104(2): 374 - 379. [Abstract] [Full Text] [PDF] T. Papayannopoulou Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization Blood, March 1, 2004; 103(5): 1580 - 1585. [Abstract] [Full Text] [PDF] J. C. Langer, E. Henckaerts, J. Orenstein, and H.-W. Snoeck Quantitative Trait Analysis Reveals Transforming Growth Factor-{beta}2 as a Positive Regulator of Early Hematopoietic Progenitor and Stem Cell Function J. Exp. Med., January 5, 2004; 199(1): 5 - 14. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Henckaerts, E. Articles by Snoeck, H.-W. Search for Related Content PubMed PubMed Citation Articles by Henckaerts, E. Articles by Snoeck, H.-W. Related Collections Hematopoiesis and Stem Cells Social Bookmarking                   What's this?

	Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020